2023-04-01 2024-03-31 false Capium Accounts Production 1.1 06672358 bus:AbridgedAccounts 2023-04-01 2024-03-31 06672358 bus:FRS102 2023-04-01 2024-03-31 06672358 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 06672358 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 06672358 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 06672358 2023-04-01 2024-03-31 06672358 2024-03-31 06672358 bus:RegisteredOffice 2023-04-01 2024-03-31 06672358 core:WithinOneYear 2024-03-31 06672358 core:AfterOneYear 2024-03-31 06672358 bus:Director1 2023-04-01 2024-03-31 06672358 bus:Director1 2024-03-31 06672358 bus:Director1 2022-04-01 2023-03-31 06672358 bus:Director2 2023-04-01 2024-03-31 06672358 bus:Director2 2024-03-31 06672358 bus:Director2 2022-04-01 2023-03-31 06672358 bus:Director3 2023-04-01 2024-03-31 06672358 bus:Director3 2024-03-31 06672358 bus:Director3 2022-04-01 2023-03-31 06672358 2022-04-01 06672358 bus:LeadAgentIfApplicable 2023-04-01 2024-03-31 06672358 2022-04-01 2023-03-31 06672358 2023-03-31 06672358 core:WithinOneYear 2023-03-31 06672358 core:AfterOneYear 2023-03-31 06672358 bus:EntityAccountantsOrAuditors 2022-04-01 2023-03-31 06672358 core:PlantMachinery 2023-04-01 2024-03-31 06672358 core:PlantMachinery 2024-03-31 06672358 core:PlantMachinery 2023-03-31 06672358 core:MotorCars 2023-04-01 2024-03-31 06672358 core:MotorCars 2024-03-31 06672358 core:MotorCars 2023-03-31 06672358 core:FurnitureFittings 2023-04-01 2024-03-31 06672358 core:FurnitureFittings 2024-03-31 06672358 core:FurnitureFittings 2023-03-31 06672358 core:ComputerEquipment 2023-04-01 2024-03-31 06672358 core:ComputerEquipment 2024-03-31 06672358 core:ComputerEquipment 2023-03-31 06672358 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-03-31 06672358 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-03-31 06672358 core:NetGoodwill 2023-04-01 2024-03-31 06672358 core:NetGoodwill 2024-03-31 06672358 core:NetGoodwill 2023-03-31 06672358 core:CostValuation core:Non-currentFinancialInstruments 2024-03-31 06672358 core:CostValuation core:Non-currentFinancialInstruments 2023-03-31 06672358 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-03-31 06672358 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-03-31 06672358 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-03-31 06672358 core:Non-currentFinancialInstruments 2024-03-31 06672358 core:Non-currentFinancialInstruments 2023-03-31 06672358 core:ShareCapital 2024-03-31 06672358 core:ShareCapital 2023-03-31 06672358 core:RetainedEarningsAccumulatedLosses 2024-03-31 06672358 core:RetainedEarningsAccumulatedLosses 2023-03-31 06672358 dpl:Item1 2023-04-01 06672358 dpl:Item1 2024-03-31 06672358 dpl:Item1 2022-04-01 06672358 dpl:Item1 2023-03-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 06672358
England and Wales

 

 

 

NPL MEDICAL SERVICES LIMITED


Abridged Accounts
 


Period of accounts

Start date: 01 April 2023

End date: 31 March 2024
Report to the directors on the preparation of the unaudited statutory accounts of NPL Medical Services Limited for the year ended 31 March 2024
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of NPL Medical Services Limited for the year ended 31 March 2024 which comprise of the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the companys accounting records and from information and explanations you have given us.      
As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at
http://rulebook.accaglobal.com/
This report is made solely to the Board of Directors of NPL Medical Services Limited, as a body, in accordance with the terms of our engagement letter dated 21 October 2024 Our work has been undertaken solely to prepare for your approval the accounts of NPL Medical Services Limited and state those matters that we have agreed to state to the Board of Directors of NPL Medical Services Limited, as a body, in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at http://www.accaglobal.com/factsheet163. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than NPL Medical Services Limited and its Board of Directors as a body for our work or for this report.
It is your duty to ensure that NPL Medical Services Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of NPL Medical Services Limited. You consider that NPL Medical Services Limited is exempt from the statutory audit requirement for the year
We have not been instructed to carry out an audit or a review of the accounts of NPL Medical Services Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts
31 March 2024



....................................................
Whitfield Jones
Avon House
19 Stanwell Road
Penarth
CF64 2EZ
21 October 2024
1
 
 
Notes
 
2024
£
  2023
£
Fixed assets      
Tangible fixed assets 4 17,498    4,081 
17,498    4,081 
Current assets      
Stocks 4,000    4,000 
Debtors 33,974    30,299 
Cash at bank and in hand 177    8,305 
38,151    42,604 
Creditors: amount falling due within one year (52,702)   (38,458)
Net current assets (14,551)   4,146 
 
Total assets less current liabilities 2,947    8,227 
Provisions for liabilities (998)   (999)
Net assets 1,949    7,228 
 

Capital and reserves
     
Called up share capital 110    110 
Profit and loss account 1,839    7,118 
Shareholders' funds 1,949    7,228 
 


For the year ended 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the board of directors on 21 October 2024 and were signed on its behalf by:


-------------------------------
Mr N Lewis
Director
2
General Information
NPL Medical Services Limited is a private company, limited by shares, registered in England and Wales, registration number 06672358, registration address 33 Cwrt-Ty-Mawr, Caerphilly, CF83 3EQ.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared on the going concern basis and under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Government grants
Government grants received are credited to deferred income. Grants towards capital expenditure are released to the income statement over the expected useful life of the assets. Grants received towards revenue expenditure are released to the income statement as the related expenditure is incurred.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted
Deferred taxation
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the reporting date.
Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Current and deferred tax assets and liabilities are not discounted.
Intangible assets
Intangible assets (including purchased goodwill and patents) are amortised at rates calculated to write off the assets on a straight line basis over their estimated useful economic lives. Impairment of intangible assets is only reviewed where circumstances indicate that the carrying value of an asset may not be fully recoverable.
Goodwill
Acquired goodwill is stated at cost less amortisation. Amortisation is calculated on a straight line basis over the estimated expected useful economic life of the goodwill of years.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:


Plant and Machinery      -    25% Reducing Balance
Fixtures and Fittings      -    20% Reducing Balance
Computer Equipment    -    20% Reducing Balance
Stocks
Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow moving items. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads.
Provisions
Provisions are recognised when the company has a present obligation as a result of a past event which it is more probable than not will result in an outflow of economic benefits that can be reasonably estimated.
2.

Average number of employees


Average number of employees during the year was 3 (2023 : 3).
3.

Intangible fixed assets

Cost Goodwill   Total
  £   £
At 01 April 2023 9,600    9,600 
Additions  
Disposals  
At 31 March 2024 9,600    9,600 
Amortisation
At 01 April 2023 9,600    9,600 
Charge for year  
On disposals  
At 31 March 2024 9,600    9,600 
Net book values
At 31 March 2024  
At 31 March 2023  


4.

Tangible fixed assets

Cost or valuation Plant and Machinery   Motor Vehicles   Fixtures and Fittings   Computer Equipment   Total
  £   £   £   £   £
At 01 April 2023 6,576      4,869    4,196    15,641 
Additions   17,910        17,910 
Disposals        
At 31 March 2024 6,576    17,910    4,869    4,196    33,551 
Depreciation
At 01 April 2023 5,128      3,576    3,338    12,042 
Charge for year   3,582    258    171    4,011 
On disposals        
At 31 March 2024 5,128    3,582    3,834    3,509    16,053 
Net book values
Closing balance as at 31 March 2024 1,448    14,328    1,035    687    17,498 
Opening balance as at 01 April 2023 1,930      1,293    858    4,081 


3